Portal
DEEN

Milestones

Our milestones trace the journey from the initial idea to a market-ready solution – with each step, we developed new features, built partnerships, and consistently enhanced the user experience.

The milestones below highlight not only key stages of our journey but also our commitment to delivering smart health solutions that truly make a difference in everyday life.

2025

Withings and myritmo cooperate:

The partnership was announced in January at CES (Las Vegas). myritmo is now integrated into the Withings Health App and available to millions of Withings users.

  • Internationalization: Since January, CardioCheck is available across France; other countries like the UK are set to follow throughout the year
  • Medical device class IIa: myritmo-analytics AI analysis platform approved as a Class IIa medical device
  • Management: Stefan Gazinski appointed as additional managing director
  • Sales expansion: Building an in-house sales structure

“Bild Heart Summit”

myritmo is invited to the first „Bild Heart Summit“ in Berlin and becomes part of the German Heart Alliance.

  • Barmer: Becomes another major private health insurance customer
  • Charité Berlin and Heidelberg University Hospital implement myritmo
  • 30,000th long-term ECG report
  • 96% recommendation rate from customers
  • AI platform: “myritmo-analytics” detects 21 arrhythmias with highest accuracy
  • Top 10 AI startup: Recognized by the federal government and invited to investor talks in New York and Palo Alto
  • First use of Mini-ECG in a 4-week-old infant: Excellent recording quality

2024

2023

“CardioCheck” Market Launch

Smartwatch ECGs evaluated within 24h – incl. medical interpretation, independent of brand, globally unique.

  • CardioCheck “Heart Metal Challenge” at the world’s largest heavy metal festival in WACKEN
  • Awards: Winner at StartUpChamp Hamburg 2023 and 2nd place in “Electrifying Ideas Award”
  • Telemedicine: First time offering direct medical consultation for customers
  • myritmo app: Enables remote physician connection in less than 15 minutes – “Plug&Play”
  • University Hospital Eppendorf, Medical School Hannover, and University Hospital Schleswig-Holstein implement myritmo
  • 1,000 evaluations processed monthly and growing

“Gunnar Uldall Award”

myritmo wins the Northern German Business Award and takes second place in the prestigious Hamburg Founder Award.

  • Allianz: another major health insurance company has become a customer
  • CES Las Vegas myritmo was invited by the German government and has its own stand
  • Web-Summit: in Lisbon with our own stand.
  • “AI-Start-Up HUB“ selected by the German government for the funded accelerator program
  • AI-based automatic ECG evaluation developed.
  • 10,000th long-term ECG assessment
  • “myritmo” launch of the brand

2022

2021

“German Medical Award”

Winner of the renowned German Medical Award at the world’s largest medical trade show Medica in Düsseldorf. Awarded in the category “Medical Innovation Product”.

  • Philip Nölling appointed as managing director.
  • EU-wide approval for AI-based analysis software to detect atrial fibrillation as Class IIa medical device (CE 0633).
  • Barmer Ersatzkasse: first IV contract with a statutory health insurer.
  • Proof-of-concept: for proprietary AI-based long-term ECG analysis for detecting all arrhythmias.
  • Online shop: ECG tests now available for order and shipping across Germany.

“EU-wide approval”

The mini long-term ECG “ritmo” is approved as a Class IIa medical device (CE 0633).

  • HanseMerkur: health insurance joins as first major customer.
  • dpv-website: launch and beginning of operational activities.
  • Approval as a layperson device: The mini long-term ECG “ritmo” can be shipped directly to patients and used independently due to its layperson classification.

2020

2019

“Wireless mini long-term ECG”

Development of the wireless mini long-term ECG “ritmo” together with German med-tech company livetec GmbH.

Programming of AI-based analysis software for reliable atrial fibrillation detection in collaboration with Psiori GmbH. AI trained using data from 250,000 individual patient records compiled by the founding doctors.

“Founding”

dpv-analytics GmbH founded by experienced physicians Dr. Ekkehard Schmidt, Dr. Stephan Kranz, and Dr. Matthias Glawe.

Vision: Fast, simple, and reliable heart screening for everyone!

2018